Combivir (Lamivudine, Zidovudine)
Canadian Meds |
Policy | Legal
Terms | Meds Index
Lamivudine/Zidovudine GSK are the medicines that contain two active substances. Lamivudine (150 mg) and Zidovudine (300 mg). These tablets are available as red capsule-shaped. These are antiviral drugs that are used in combination with at least with one other antiviral medicine which are used for the treatment of HIV (human immunodeficiency virus) that causes AIDS in human beings. It has been developed with the co-operation of WHO (world health organization) and hence this medicine is available only with a doctor’s prescription. Since HIV is a critical disease, the treatment with Lamivudine/Zidovudine GSK should be given by the doctor who must be an expert or at least experienced in the field of HIV infection.
How to use
Medicines are consumed according to the human weight. For the adults who are with at least 30kgs of weight, a single Lamivudine/Zidovudine GSK tablet has to be taken twice a day. In case of children’s whose weights are between 14-30kgs, number of tablets and half tablets can be taken according to the weight. Separate tablets containing Lamivudine/Zidovudine GSK are used in case of children whose weight is less than 14 kg. Children’s who are taking this tablet should be closely watched for side effects.
Tablets can be taken after consulting with doctor. They can be consumed before or after meal. Do not miss any of the doses. If a particular dose is missed, take as soon as possible but make sure that all doses are not taken at a same time on a particular day. Do not stop the dose until the dosage period gets over.
The patients who are affected with advanced HIV, blood disorders (which mainly includes low white blood cell levels, severe anemia), muscle pain and inflammation, are associated with zidovudine. It is one of the active ingredients of combivir. Usage of combivir can even cause high level of lactic acid inside the blood and severe liver problems also occur which are threatening diseases.
© 2003-2017 Rx Meds Canada . All Rights Reserved